Leon O. Moulder, Jr.

Former President, Chief Executive Officer & Director at MGI Pharma, Inc.

Leon O. Moulder, Jr.

Leon O. Moulder, Jr.

Former President, Chief Executive Officer & Director at MGI Pharma, Inc.

Overview
Career Highlights

MGI Pharma, Inc.
Abraxis BioScience, Inc.
TESARO, Inc.

RelSci Relationships

1432

Number of Boards

12

Birthday

1957

Age

62

Contact Data
Trying to get in touch with Leon O. Moulder, Jr.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Leon O. Moulder, Jr. likely has professional access to. A relationship does not necessarily indicate a personal connection.

Professional at GlaxoSmithKline Plc

Relationship likelihood: Strong

Founder at Trevena, Inc.

Relationship likelihood: Strong

Professor of Medicine at University of Nebraska Medical Center

Relationship likelihood: Strong

General Partner at NEA Management Co. LLC

Relationship likelihood: Strong

Former President, Chief Executive Officer & Director, NPS Pharmaceuticals, Inc at NPS Pharmaceuticals, Inc.

Relationship likelihood: Strong

Former Professional at Aqua America, Inc.

Relationship likelihood: Strong

Founder at Biotechnology Innovation Organization

Relationship likelihood: Strong

Director & Vice Chairman-Food Governing Body at Biotechnology Innovation Organization

Relationship likelihood: Strong

President at Chf, Inc.

Relationship likelihood: Strong

Former Chief Operating Officer & Executive Vice President at Endo Health Solutions, Inc.

Relationship likelihood: Strong

Paths to Leon O. Moulder, Jr.
Potential Connections via
Relationship Science
You
Leon O. Moulder, Jr.
Former President, Chief Executive Officer & Director at MGI Pharma, Inc.
Education
BS in Pharmacy

Temple University is a national center of excellence in teaching and research with an international presence. Our talented faculty and broad curriculum of over 400 academic programs provide superior educational opportunities for academically talented and highly motivated students, without regard to their status or station in life.

MBA

The University of Chicago Booth School of Business is a graduate business school located in Chicago, Illinois, at the University of Chicago. Formerly known as the University of Chicago Graduate School of Business, Chicago Booth is the second-oldest business school in the U.S., the first such school to offer an Executive MBA program, and the first to initiate a Ph.D. program in business. The school was renamed in 2008 following a $300 million endowment gift to the school by alumnus David G. Booth. The school has the third-largest endowment of any business school. The school's flagship campus is located in the Hyde Park neighborhood of Chicago on the main campus of the university. The school also maintains additional campuses in London and Asia (originally Singapore, but in July 2013 a move to Hong Kong was announced), as well as in downtown Chicago on the Magnificent Mile. In addition to conducting graduate business programs, the school conducts research in the fields of finance, economics, quantitative marketing research, and accounting. Chicago Booth is currently ranked first in the United States by Bloomberg Businessweek and first globally by the Economist.

Career History
President, Chief Executive Officer & Director
1999 - 2008

MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN.

Co-Founder
2010 - 2019

TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. It focuses on oncology-based therapeutics and its products include: Rolapitant and Niraparib. The company was founded by Leon Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA.

Vice Chairman, President & Chief Executive Officer
2009 - 2010

Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA.

Transactions
Details Hidden

TESARO, Inc. raised money in a private placement transaction

Details Hidden

TESARO, Inc. raised money in a private placement transaction

Details Hidden

TESARO, Inc. raised money in a private placement transaction

Investments
Details Hidden

TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. It focuses on oncology-based therapeutics and its products include: Rolapitant and Niraparib. The company was founded by Leon Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Leon O. Moulder, Jr.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Leon O. Moulder, Jr.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Leon O. Moulder, Jr..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/leon-o-moulder-jr-3254317
  • https://relationshipscience.com/person/leon-o-moulder-jr-3254317